Investor Relations

Our mission is to transform healthcare by redefining and restoring the functional health of the gut microbiome, which we recognize as a vital organ. Through our innovative diagnostic management tools and microbiome-based interventions, we aim to improve health span and longevity, prevent and treat chronic diseases, and shift the focus from sick care to true healthcare.

Latest Investor Update
download pdf

Pipeline 
Learn More

Press Releases